Ardelyx (ARDX) Depreciation & Amortization (CF) (2013 - 2026)
Ardelyx posted quarterly Depreciation & Amortization (CF) of $915000.0 for Q1 2026, up 51.99% year-on-year from $602000.0 in Q1 2025, and down 0.65% on a QoQ basis from $921000.0 in Q4 2025.
Ardelyx (ARDX) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $915000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 51.99% year-over-year to $915000.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (up 51.21% YoY), and the FY2025 full-year result was $3.1 million, up 48.28% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $915000.0, down from $921000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $921000.0 in Q4 2025 and bottomed at -$3000.0 in Q1 2023.
- The 5-year median for Depreciation & Amortization (CF) is $515000.0 (2024), against an average of $498411.8.
- The widest annual swing landed in 2023, when Depreciation & Amortization (CF) slumped 100.65%; it then soared 14600.0% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $127000.0 in 2022, then jumped by 185.04% to $362000.0 in 2023, then soared by 42.27% to $515000.0 in 2024, then jumped by 78.83% to $921000.0 in 2025, then fell by 0.65% to $915000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $915000.0 (Q1 2026), $921000.0 (Q4 2025), and $905000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 915,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 915,000.00 |
| Mar 31, 2026 | 915,000.00 |
| Dec 31, 2025 | 921,000.00 |
| Dec 31, 2025 | 921,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 631,000.00 |
| Jun 30, 2025 | 631,000.00 |
| Mar 31, 2025 | 602,000.00 |
| Mar 31, 2025 | 602,000.00 |
| Dec 31, 2024 | 515,000.00 |
| Dec 31, 2024 | 515,000.00 |
| Sep 30, 2024 | 544,000.00 |
| Sep 30, 2024 | 544,000.00 |
| Jun 30, 2024 | 569,000.00 |
| Jun 30, 2024 | 569,000.00 |
| Mar 31, 2024 | 435,000.00 |
| Mar 31, 2024 | 435,000.00 |
| Dec 31, 2023 | 362,000.00 |
| Dec 31, 2023 | 362,000.00 |
| Sep 30, 2023 | 291,000.00 |
| Sep 30, 2023 | 291,000.00 |
| Jun 30, 2023 | 642,000.00 |
| Jun 30, 2023 | 642,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 279,000.00 |
| Sep 30, 2022 | 279,000.00 |
| Jun 30, 2022 | 275,000.00 |
| Jun 30, 2022 | 275,000.00 |
| Mar 31, 2022 | 463,000.00 |
| Mar 31, 2022 | 463,000.00 |
| Dec 31, 2021 | 495,000.00 |
| Dec 31, 2021 | 495,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Mar 31, 2020 | 492,000.00 |
| Mar 31, 2020 | 492,000.00 |
| Dec 31, 2019 | 508,000.00 |
| Dec 31, 2019 | 508,000.00 |
| Sep 30, 2019 | 640,000.00 |
| Sep 30, 2019 | 640,000.00 |
| Jun 30, 2019 | 678,000.00 |
| Jun 30, 2019 | 678,000.00 |
| Mar 31, 2019 | 675,000.00 |
| Mar 31, 2019 | 675,000.00 |
| Dec 31, 2018 | 673,000.00 |
| Dec 31, 2018 | 673,000.00 |
| Sep 30, 2018 | 662,000.00 |
| Sep 30, 2018 | 662,000.00 |
| Jun 30, 2018 | 669,000.00 |
| Jun 30, 2018 | 669,000.00 |
| Mar 31, 2018 | 674,000.00 |
| Mar 31, 2018 | 674,000.00 |
| Dec 31, 2017 | 674,000.00 |
| Dec 31, 2017 | 674,000.00 |
| Sep 30, 2017 | 723,000.00 |
| Sep 30, 2017 | 723,000.00 |
| Jun 30, 2017 | 648,000.00 |
| Jun 30, 2017 | 648,000.00 |
| Mar 31, 2017 | 594,000.00 |
| Mar 31, 2017 | 594,000.00 |
| Dec 31, 2016 | 391,000.00 |
| Dec 31, 2016 | 391,000.00 |
| Sep 30, 2016 | 273,000.00 |
| Sep 30, 2016 | 273,000.00 |
| Jun 30, 2016 | 321,000.00 |
| Jun 30, 2016 | 321,000.00 |
| Mar 31, 2016 | 310,000.00 |
| Mar 31, 2016 | 310,000.00 |
| Dec 31, 2015 | 289,000.00 |
| Dec 31, 2015 | 289,000.00 |
| Sep 30, 2015 | 262,000.00 |
| Sep 30, 2015 | 262,000.00 |
| Jun 30, 2015 | 159,000.00 |
| Jun 30, 2015 | 159,000.00 |
| Mar 31, 2015 | 119,000.00 |
| Mar 31, 2015 | 119,000.00 |
| Dec 31, 2014 | 98,000.00 |
| Dec 31, 2014 | 98,000.00 |
| Sep 30, 2014 | 74,000.00 |
| Sep 30, 2014 | 74,000.00 |
| Jun 30, 2014 | 55,000.00 |
| Jun 30, 2014 | 55,000.00 |
| Mar 31, 2014 | 73,000.00 |
| Mar 31, 2014 | 73,000.00 |
| Dec 31, 2013 | 88,000.00 |
| Dec 31, 2013 | 88,000.00 |
| Sep 30, 2013 | 156,000.00 |
| Sep 30, 2013 | 156,000.00 |